Precision Oncology market is set for strong growth through 2035, fueled by genomic advances, rising cancer cases, and increased use of targeted therapies.

Based on promising preclinical data, researchers hope to begin clinically testing PLK1-targeted treatments in young people with fibrolamellar carcinoma.

Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications ...

With the future of her cancer treatment in limbo, Natalie Phelps doesn’t know how much longer she can wait. Last month, after months of seeking treatment options for her colorectal cancer, the 43-year ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found. The group ...

If you have a tumor developing in the area of your brain that controls the left side of your body, for example, you may notice twitching only in your left arm or leg. Seizures usually last just a few ...

A tumor classified as being progressive has likely grown substantially ... this may no longer be the case. An example is with immunotherapy medications. Rarely do people who have good responses to ...

Review was made of the medical charts of all patients with Wilms's tumor (nephroblastoma, embryoma of the kidney) currently listed in the diagnostic files of six hospitals and diagnosed between ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

Transurethral resection of bladder tumor (TURBT, also known as transurethral resection, or TUR) is the most common surgery for bladder cancer that’s in early stages. Doctors take samples of ...

As previously reported, the primary efficacy endpoint was successfully achieved in 95.5% of tumors treated as measured by the number of tumors where complete tumor coverage was achieved (42/44).

Secondary efficacy end points included the best tumor response during maintenance therapy ... The limitations associated with the current study include its small sample size, insufficient power to ...